Clinical Trial Update: Study Evaluating Rhapsody Registry in Patients With Depression and Anxiety

View source ↗

Summary

The update indicates the Rhapsody Registry trial in patients with depression and anxiety has completed; pain is also listed among the conditions studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Pain, Depression | Status: COMPLETED